Global Advanced Wound Care Market Synopsis
The Global Advanced Wound Care Market size was reasonably estimated to be approximately USD 10699.1 Million in 2023 and is poised to generate revenue over USD 14,511.30 Million by the end of 2030, projecting a CAGR of around 4.45% from 2023 to 2030.
The advanced wound care market refers to the healthcare industry sector that focuses on treating and managing complex and chronic wounds. It involves the use of advanced wound care products and therapies to promote wound healing, reduce infection risks, and improve patient outcomes.
- Advanced wound care is a type of medical treatment that is used to treat wounds that have not healed properly. Advanced wound care can be divided into three main categories: wound healing, infection prevention, and restoration. Wound healing is the process by which the skin heals itself. This includes the formation of new skin cells, the growth of new blood vessels, and the removal of dead tissue. Infection is the prevention of infection from entering a wound.
- This can be done by cleaning the wound with appropriate antibacterial solutions, using sterile dressings, and using antibiotics if needed. Restoration is the rebuilding of tissue that has been damaged or lost due to injury. This can include the growth of new blood vessels, the deposition of new collagen fibers, and the release of growth factors.
- Advanced wound care techniques help reduce inflammation and speed up healing. This means that wounds can heal quicker and with less pain. In some cases, wounds may close completely without additional surgery or procedures. Many people find that their wounds look better after receiving advanced wound care treatments. This is because advanced wound care techniques help reduce the amount of scarring and swelling around a wound.
Top Key Players Involved Are:
"Acelity Inc (U.S.), Adynxx, Inc. (U.S.), B Braun Melsungen AG (Germany), Coloplast A/S (Denmark), ConvaTec Group plc (UK), BSN Medical GmbH (Sweden), Integra Lifesciences (Derma Sciences) (USA), Investor AB (Mölnlycke Health Care AB) (Sweden), Johnson & Johnson (U.S), Medline Industries Inc (U.S.), Medtronic plc (Ireland), Organogenesis Holdings Inc (U.S.), Smith & Nephew Plc (United Kingdom), MiMedx (USA), Tissue Regenix (United Kingdom), Derma Sciences Inc (U.S.), Molnlycke Health Care (Sweden), Paul Hartmann AG (Germany), Baxter International (U.S.), URGO Medical (France), Other Major Players."
The Global Advanced Wound Care Market Trend Analysis
Rising Awareness Among Healthcare Professionals and Patients
- Rising awareness among healthcare professionals and patients is a significant driver of the advanced wound care market. Over the years, there has been an increasing focus on educating healthcare professionals about the importance of advanced wound care and the available treatment options. This has led to a better understanding and recognition of the benefits associated with advanced wound care products and therapies.
- With the availability of online resources and patient education materials, individuals are increasingly educated about the importance of proper wound care and the benefits of advanced wound care products. This has empowered patients to actively participate in their wound-healing process and make informed decisions about their treatment options.
- In summary, the increasing awareness among healthcare professionals and patients has played a crucial role in driving the adoption of advanced wound care solutions. It has improved the standard of wound care practice, empowered patients to actively participate in their healing process, and stimulated the demand for advanced wound care products and therapies.
Favorable Reimbursement Policies Create an Opportunity for the Market.
- Favorable reimbursement policies create a significant opportunity for the advanced wound care market by stimulating demand and facilitating the adoption of advanced wound care products and treatments. When reimbursement policies provide adequate coverage for these innovative solutions, it encourages healthcare providers to incorporate them into their practice, ensuring improved accessibility for patients.
- The financial viability offered by reimbursement policies also incentivizes manufacturers to invest in research and development, leading to continuous innovation in wound care technologies.
- Moreover, these policies promote cost-effectiveness within healthcare systems by potentially reducing complications, hospital readmissions, and overall healthcare resource utilization. Ultimately, favorable reimbursement policies not only drive market growth but also contribute to better patient outcomes and enhanced quality of wound care management.
Segmentation Analysis of the Global Advanced Wound Care Market
Global Advanced Wound Care Market Cover Product, Application, and End-Users. The Hospitals segment is anticipated to dominate the market over the forecast period.
- The hospital segment is a crucial and dominant end-user segment in the advanced wound care market. Hospitals are at the forefront of wound management, providing comprehensive care to patients with complex wounds and critical conditions. They have specialized wound care units, including wound clinics, burn centers, and surgical departments, where healthcare professionals employ advanced wound care techniques and products.
- Hospitals offer a wide range of advanced wound care treatments and interventions, such as negative pressure wound therapy (NPWT), bioactive dressings, and advanced wound dressings. These treatments are often performed by trained wound care specialists, including wound care nurses and healthcare providers with expertise in wound management.
- Overall, the hospital segment plays a dominant role in the advanced wound care market due to its specialized infrastructure, expertise, and ability to handle a wide range of wounds. Hospitals are at the forefront of delivering advanced wound care services and are significant contributors to the growth and development of the market.
Source: Statista
According to the graph, Colombia has the highest number of hospitals, with 10,899, followed by Japan and the United States. This significant number of hospitals presents an advantage for the advanced wound care market. As hospitals play a dominant role in adopting and utilizing advanced wound care products and treatments, the high number of hospitals in these countries indicates a potential larger market for advanced wound care solutions.
Regional Analysis of the Global Advanced Wound Care Market
North America is Expected to Dominate the Market over the Forecast Period.
- North America has a well-established healthcare infrastructure with advanced medical facilities and a high level of awareness and adoption of advanced wound care technologies. The region boasts a robust network of hospitals, wound care centers, and clinics equipped with state-of-the-art wound care products and treatments. The availability of specialized wound care professionals and the implementation of advanced wound care protocols contribute to the region's dominance.
- The prevalence of chronic wounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers, is relatively high in North America. Factors like an aging population, a rise in obesity rates, and an increased incidence of diabetes contribute to the growing burden of chronic wounds. This drives the demand for advanced wound care products and therapies in the region.
- Additionally, favorable reimbursement policies in North America, particularly in the United States, support the adoption of advanced wound care treatments and products. Reimbursement coverage for these products and therapies encourages healthcare providers to incorporate them into their practice, ensuring improved accessibility for patients.
COVID-19 Impact on the Global Advanced Wound Care Market
- The pandemic has strained healthcare systems worldwide, with resources and healthcare personnel being redirected to address COVID-19 cases. This redirection of resources has led to a reduction in elective surgeries and non-emergency procedures, including wound care treatments. As a result, the demand for advanced wound care products and services has been temporarily affected.
- The pandemic has accelerated the adoption of telemedicine and remote monitoring technologies. Healthcare providers have increasingly used virtual consultations and remote wound monitoring to minimize in-person visits. This shift in healthcare delivery has impacted the demand for specific advanced wound care products, such as digital wound management systems and remote monitoring devices.
- It is important to note that the impact of COVID-19 on the advanced wound care market has been complex and multifaceted. While there have been challenges, such as disruptions and delayed care, the pandemic has also highlighted the importance of advanced wound care and infection control measures. As the situation evolves, the market is expected to recover and adapt to the changing needs of wound care management in a post-pandemic world.
Top Key Players in the Global Advanced Wound Care Market
- Acelity Inc (U.S.)
- Adynxx Inc (U.S)
- B Braun Melsungen AG (Germany)
- Coloplast A/S (Denmark)
- ConvaTec Group plc (Uk)
- BSN Medical GmbH (Sweden)
- Derma Sciences (U.S.)
- Mölnlycke Health Care AB (Sweden)
- Johnson & Johnson (U.S.)
- Medline Industries Inc (U.S)
- Medtronic plc (Ireland)
- Organogenesis Holdings Inc (U.S)
- Smith & Nephew Plc (UK)
- MiMedx (U.S)
- Tissue Regenix (United Kingdom)
- Derma Sciences Inc (U.S.)
- Molnlycke Health Care (Sweden)
- Paul Hartmann AG (Germany)
- Baxter International (U.S.)
- URGO Medical (France) and Other Major Players.
Key Industry Developments in the Global Advanced Wound Care Market
In March 2022, Urgo Medical has been warmly welcomed as a new partner by the International Diabetes Federation (IDF). Urgo Medical, a global wound care company, strongly advocates for collaborative efforts in promoting prevention, early detection, proper referral, and effective care to prevent foot ulcerations and associated complications in individuals with diabetes. They firmly believe that by working together, significant progress can be made in addressing this issue.
In October 2018, Alliqua BioMedical Inc and privately held biopharmaceutical company Adynxx Inc signed a definitive merger agreement. Under the agreement, the stockholders of Adynxx will become the majority owners of Alliqua's outstanding common stock on a fully-diluted basis. The merger aims to establish a clinical-stage pharmaceutical company focused on the development of a platform of innovative, non-opioid therapies that can modify the course of pain conditions.
Global Advanced Wound Care Market
|
Base Year:
|
2022
|
Forecast Period:
|
2023-2030
|
Historical Data:
|
2016 to 2021
|
Market Size in 2022:
|
USD 10699.1 Mn.
|
Forecast Period 2023-30 CAGR:
|
4.45%
|
Market Size in 2032:
|
USD 14,511.30 Mn.
|
Segments Covered:
|
By Product
|
- Infection Management Exudate Management
- Active Wound Care and Therapy Devices
|
By Application
|
- Chronic Wounds
- Acute Wounds
|
By End Users
|
- Hospitals
- Community Health Service Centers
|
By Region
|
- North America (U.S., Canada, Mexico)
- Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
- Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
- Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
- Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
- South America (Brazil, Argentina, Rest of SA)
|
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Product
3.2 By Application
3.3 By End User
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Advanced Wound Care Market by Product
5.1 Advanced Wound Care Market Overview Snapshot and Growth Engine
5.2 Advanced Wound Care Market Overview
5.3 Infection Management Exudate Management
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Infection Management Exudate Management: Geographic Segmentation
5.4 Active Wound Care and Therapy Devices
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Active Wound Care and Therapy Devices: Geographic Segmentation
Chapter 6: Advanced Wound Care Market by Application
6.1 Advanced Wound Care Market Overview Snapshot and Growth Engine
6.2 Advanced Wound Care Market Overview
6.3 Chronic Wounds
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Chronic Wounds: Geographic Segmentation
6.4 Acute Wounds
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Acute Wounds: Geographic Segmentation
Chapter 7: Advanced Wound Care Market by End User
7.1 Advanced Wound Care Market Overview Snapshot and Growth Engine
7.2 Advanced Wound Care Market Overview
7.3 Hospitals
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size (2016-2030F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals: Geographic Segmentation
7.4 Community Health Service Centers
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size (2016-2030F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Community Health Service Centers: Geographic Segmentation
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Positioning
8.1.2 Advanced Wound Care Sales and Market Share By Players
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Advanced Wound Care Industry Concentration Ratio (CR5 and HHI)
8.1.6 Top 5 Advanced Wound Care Players Market Share
8.1.7 Mergers and Acquisitions
8.1.8 Business Strategies By Top Players
8.2 ACELITY INC (U.S.)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Operating Business Segments
8.2.5 Product Portfolio
8.2.6 Business Performance
8.2.7 Key Strategic Moves and Recent Developments
8.2.8 SWOT Analysis
8.3 ADYNXX
8.4 INC. (U.S.)
8.5 B BRAUN MELSUNGEN AG (GERMANY)
8.6 COLOPLAST A/S (DENMARK)
8.7 CONVATEC GROUP PLC (UK)
8.8 BSN MEDICAL GMBH (SWEDEN)
8.9 INTEGRA LIFESCIENCES (DERMA SCIENCES) (USA)
8.10 INVESTOR AB (MÖLNLYCKE HEALTH CARE AB) (SWEDEN)
8.11 JOHNSON & JOHNSON (U.S)
8.12 MEDLINE INDUSTRIES INC (U.S.)
8.13 MEDTRONIC PLC (IRELAND)
8.14 ORGANOGENESIS HOLDINGS INC (U.S.)
8.15 SMITH & NEPHEW PLC (UNITED KINGDOM)
8.16 MIMEDX (USA)
8.17 TISSUE REGENIX (UNITED KINGDOM)
8.18 DERMA SCIENCES INC (U.S.)
8.19 MOLNLYCKE HEALTH CARE (SWEDEN)
8.20 PAUL HARTMANN AG (GERMANY)
8.21 BAXTER INTERNATIONAL (U.S.)
8.22 URGO MEDICAL (FRANCE)
8.23 OTHER MAJOR PLAYERS
Chapter 9: Global Advanced Wound Care Market Analysis, Insights and Forecast, 2016-2030
9.1 Market Overview
9.2 Historic and Forecasted Market Size By Product
9.2.1 Infection Management Exudate Management
9.2.2 Active Wound Care and Therapy Devices
9.3 Historic and Forecasted Market Size By Application
9.3.1 Chronic Wounds
9.3.2 Acute Wounds
9.4 Historic and Forecasted Market Size By End User
9.4.1 Hospitals
9.4.2 Community Health Service Centers
Chapter 10: North America Advanced Wound Care Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Product
10.4.1 Infection Management Exudate Management
10.4.2 Active Wound Care and Therapy Devices
10.5 Historic and Forecasted Market Size By Application
10.5.1 Chronic Wounds
10.5.2 Acute Wounds
10.6 Historic and Forecasted Market Size By End User
10.6.1 Hospitals
10.6.2 Community Health Service Centers
10.7 Historic and Forecast Market Size by Country
10.7.1 US
10.7.2 Canada
10.7.3 Mexico
Chapter 11: Eastern Europe Advanced Wound Care Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Product
11.4.1 Infection Management Exudate Management
11.4.2 Active Wound Care and Therapy Devices
11.5 Historic and Forecasted Market Size By Application
11.5.1 Chronic Wounds
11.5.2 Acute Wounds
11.6 Historic and Forecasted Market Size By End User
11.6.1 Hospitals
11.6.2 Community Health Service Centers
11.7 Historic and Forecast Market Size by Country
11.7.1 Bulgaria
11.7.2 The Czech Republic
11.7.3 Hungary
11.7.4 Poland
11.7.5 Romania
11.7.6 Rest of Eastern Europe
Chapter 12: Western Europe Advanced Wound Care Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Product
12.4.1 Infection Management Exudate Management
12.4.2 Active Wound Care and Therapy Devices
12.5 Historic and Forecasted Market Size By Application
12.5.1 Chronic Wounds
12.5.2 Acute Wounds
12.6 Historic and Forecasted Market Size By End User
12.6.1 Hospitals
12.6.2 Community Health Service Centers
12.7 Historic and Forecast Market Size by Country
12.7.1 Germany
12.7.2 UK
12.7.3 France
12.7.4 Netherlands
12.7.5 Italy
12.7.6 Russia
12.7.7 Spain
12.7.8 Rest of Western Europe
Chapter 13: Asia Pacific Advanced Wound Care Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Product
13.4.1 Infection Management Exudate Management
13.4.2 Active Wound Care and Therapy Devices
13.5 Historic and Forecasted Market Size By Application
13.5.1 Chronic Wounds
13.5.2 Acute Wounds
13.6 Historic and Forecasted Market Size By End User
13.6.1 Hospitals
13.6.2 Community Health Service Centers
13.7 Historic and Forecast Market Size by Country
13.7.1 China
13.7.2 India
13.7.3 Japan
13.7.4 South Korea
13.7.5 Malaysia
13.7.6 Thailand
13.7.7 Vietnam
13.7.8 The Philippines
13.7.9 Australia
13.7.10 New Zealand
13.7.11 Rest of APAC
Chapter 14: Middle East & Africa Advanced Wound Care Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Product
14.4.1 Infection Management Exudate Management
14.4.2 Active Wound Care and Therapy Devices
14.5 Historic and Forecasted Market Size By Application
14.5.1 Chronic Wounds
14.5.2 Acute Wounds
14.6 Historic and Forecasted Market Size By End User
14.6.1 Hospitals
14.6.2 Community Health Service Centers
14.7 Historic and Forecast Market Size by Country
14.7.1 Turkey
14.7.2 Bahrain
14.7.3 Kuwait
14.7.4 Saudi Arabia
14.7.5 Qatar
14.7.6 UAE
14.7.7 Israel
14.7.8 South Africa
Chapter 15: South America Advanced Wound Care Market Analysis, Insights and Forecast, 2016-2030
15.1 Key Market Trends, Growth Factors and Opportunities
15.2 Impact of Covid-19
15.3 Key Players
15.4 Key Market Trends, Growth Factors and Opportunities
15.4 Historic and Forecasted Market Size By Product
15.4.1 Infection Management Exudate Management
15.4.2 Active Wound Care and Therapy Devices
15.5 Historic and Forecasted Market Size By Application
15.5.1 Chronic Wounds
15.5.2 Acute Wounds
15.6 Historic and Forecasted Market Size By End User
15.6.1 Hospitals
15.6.2 Community Health Service Centers
15.7 Historic and Forecast Market Size by Country
15.7.1 Brazil
15.7.2 Argentina
15.7.3 Rest of SA
Chapter 16 Investment Analysis
Chapter 17 Analyst Viewpoint and Conclusion